Market Vectors Renminbi USD News - CNY | Aktien Amerikanische Börse

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Ares Genetics, a Curetis Group Company, Joins NVIDIA Inception and AWS Activate Programs

Ares Genetics selected for NVIDIA and AWS programs to accelerate commercialization of its AI-powered Universal Pathogenome Assay – ARESupaNVIDIA...

Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize

Prize awarded by the Vienna Economic Chamber to the most innovative companies in Vienna Ares Genetics´ awarded in the category Life Sciences for...

Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens

All formal FDA requests for additional information answeredInteractive review ongoing as review nears completion Amsterdam, the Netherlands...

Curetis Publishes Third Quarter and 9-Month Business and Financial Update

- Signed IVD partnership for Ares Genetics - Progressed implementation of the Curetis - OpGen business combination with S4 filing - More than...

Curetis Provides Business Update for the First Nine Months of 2019

- Signed IVD partnership for Ares Genetics - Progressed implementation of the Curetis - OpGen business combination with S4 filing - More than...

Curetis To Attend Key Conferences in the Fourth Quarter of 2019

Amsterdam, the Netherlands, and Holzgerlingen, Germany, October 30, 2019, 10:00 am CET - Curetis N.V. (the "Company" and, together with its...

Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test

Blinded evaluation study with leading global IVD player demonstrated diagnostic performance in line with FDA...

Curetis Reports Financial Results for the First Six Months of 2019

- Strategic transaction to combine businesses with OpGen Inc. - Revenues increased by approximately 35% year-on-year - Progressing regulatory...

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses Combined company creates a...

Curetis Retains H.C. Wainwright & Co. as Strategic Advisor

Investment bank supports Curetis in assessment of all strategic and tactical financing options Publication of H1-2019 financials postponed to...

Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing

Initial focus on non-diagnostic testing with Next Generation Sequencing (NGS) for infection control, outbreak management and researchFirst...

Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes

- Share issue cap of 2.75 million shares under the first tranche of EUR 5 million in Yorkville convertible...

Curetis and AKO MED Ink Distribution Agreement Covering Four Countries in CEE Region

- AKO MED to exclusively distribute Unyvero A50 portfolio in Serbia, North Macedonia, Bosnia Hercegovina, and Montenegro - Preparing inclusion...

Curetis to Present at Solebury Trout European Biotech Investor Day in NYC

Amsterdam, the Netherlands, San Diego, CA, USA, and Holzgerlingen, Germany, July 25, 2019, 08:00 am CEST - Curetis N.V. (the "Company" and...

Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens

- Final LRT BAL panel demonstrates overall weighted average sensitivity of up to 94.7% and overall weighted average specificity of up to 98.4...

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Market Vectors Renminbi USD (CNY)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

CNY Nachrichten

Ares Genetics, a Curetis Group Company, Joins NVIDIA Inception and AWS Activate Programs

Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize

Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens

Curetis Publishes Third Quarter and 9-Month Business and Financial Update

Curetis Provides Business Update for the First Nine Months of 2019

Curetis To Attend Key Conferences in the Fourth Quarter of 2019

Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test

Curetis Reports Financial Results for the First Six Months of 2019

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

Curetis Retains H.C. Wainwright & Co. as Strategic Advisor

Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing

Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes

Curetis and AKO MED Ink Distribution Agreement Covering Four Countries in CEE Region

Curetis to Present at Solebury Trout European Biotech Investor Day in NYC

Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Market Vectors Renminbi USD (CNY) News

Market Vectors Renminbi USD (CNY)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

CNY Nachrichten

Ares Genetics, a Curetis Group Company, Joins NVIDIA Inception and AWS Activate Programs

Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize

Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens

Curetis Publishes Third Quarter and 9-Month Business and Financial Update

Curetis Provides Business Update for the First Nine Months of 2019

Curetis To Attend Key Conferences in the Fourth Quarter of 2019

Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test

Curetis Reports Financial Results for the First Six Months of 2019

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

Curetis Retains H.C. Wainwright & Co. as Strategic Advisor

Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing

Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes

Curetis and AKO MED Ink Distribution Agreement Covering Four Countries in CEE Region

Curetis to Present at Solebury Trout European Biotech Investor Day in NYC

Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen